查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球鑑別診斷市場——行業規模、份額、趨勢、機會、預測、治療類型、使用性別、最終用途、地區、競爭分析 (2018-2028)
市場調查報告書
商品編碼
1244125

全球鑑別診斷市場——行業規模、份額、趨勢、機會、預測、治療類型、使用性別、最終用途、地區、競爭分析 (2018-2028)

Differential Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Treatment Type, By Usability, By End Use, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 118 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球鑑別診斷市場預計在 2024-2028 年的預測期內以穩定的複合年增長率增長。

這是由於流感、COVID 病、心髒病和傳染病等各類疾病在全球的流行率不斷上升。 通過在線平台輕鬆獲得即時檢測產品也將推動預測期內的市場增長。 同樣，醫療保健的日益分散化、項目開發的高投資和資金預計將在未來幾年推動鑑別診斷市場的增長。 由於慢性病診斷測試的可負擔性，預計新興市場將推動市場增長。 2022 年 1 月，治療用品管理局 (TGA) 初步批准了 Novavax 的 COVID-19 疫苗（品牌為 Nuvaxovid）在澳大利亞使用。

不斷上升的診斷測試

由於診斷數量的增加，人們正在尋求最好的診斷測試來輕鬆檢測疾病，這有望在預測期內推動市場增長。 診斷測試在私人或公共實驗室進行，這些實驗室配備適當的設施，有時配備昂貴的設備，並配備訓練有素的合格人員。 在傳染病診斷領域，對在最接近患者護理點進行的即時檢測的需求不斷增長，以幫助護理團隊更快地收到更多結果並做出更快、更明智的管理決策。我是要求能夠做到。 此外，在分子診斷領域，可以通過極具挑戰性的鑑別診斷來檢測不同類型的疾病。 政府和各種組織正在醫療保健領域進行研發投資，這是預測期內推動鑑別診斷市場增長的主要因素。 根據國家艾滋病控制組織 (NACO) 的數據，到 2021 年，印度約有 240 萬人感染了艾滋病毒。 在所有 HIV 感染者中，女性佔 45%，12 歲以下的佔 2%。 此外，由於診所數量的增加，鑑別診斷檢測市場的需求也在逐年增加。 根據世界衛生組織（WHO）2021年4月發布的《非傳染性疾病關鍵事實》，慢性病每年導致約4100萬人死亡，佔全球所有死亡人數的71%。

不斷進步的技術進步

診斷技術的進步使醫生能夠實時評估過程和事件。 物理學和數學進步的臨床應用導致了診斷工具的發展。 這些發展將幫助醫生做出更準確、侵入性更小且成本更低的診斷，並將在預計的年限內推動市場增長。 對家用診斷套件的需求不斷增長預計也將導致技術發展，從而在預測期內實現顯著增長。 丹納赫子公司徠卡顯微系統公司 (Leica Microsystems) 宣布將於 2020 年 4 月推出該公司革命性共聚焦顯微鏡的旗艦平台 STELLARIS。 該平台允許在三個維度上查看活組織和細胞。

市場細分

近期發展

  • 2021 年 1 月，羅氏在多個已接受 CE 標誌的國家/地區推出了“Cobas Pulse System”。 該產品是羅氏診斷公司最新一代聯網的即時護理解決方案。 最新版本允許進行專業的血糖管理。
  • 2021 年 9 月，Ortho Clinical Diagnostics 將在其 Ortho Vision 和 Ortho Vision Max Analyzers 上提供即時自旋交叉配型 (ISXM)，這是一種用於識別輸血中受體-供體不匹配的工具，宣布

參與企業

Thermo Fisher Scientific Inc.、Hologic, Inc.、Quidel Corporation.、F. Hoffmann-La Roche Ltd.、Abbott Laboratories, Inc.、Danaher Corporation、Meridian Bioscience Inc. GenMark Diagnostics, Inc.、Sekisui Diagnosis Co. , Ltd.、Luminex Corporation 等是在全球鑑別診斷市場上運營的一些主要公司。

範圍：

本報告將全球鑑別診斷市場分為以下幾類，以及下面詳述的行業趨勢：

鑑別診斷市場，按治療類型：

  • 胸痛
  • 頭痛
  • 發燒
  • 肺炎
  • 高血壓
  • 疲勞
  • 睡眠問題

鑑別診斷市場，按用途：

  • 身體健康障礙
  • 精神疾病

鑑別診斷市場，按最終用途：

  • 醫院
  • 診斷中心
  • 其他

按地區劃分的鑑別診斷市場：

  • 北美
    • 美國
    • 墨西哥
    • 加拿大
  • 歐洲
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳大利亞
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
  • 中東和非洲
    • 南非
    • 沙特阿拉伯
    • 阿聯酋
    • 埃及
    • 土耳其人

競爭格局

公司概況：對全球鑑別診斷市場主要參與者的詳細分析。

可自定義：

根據市場數據，TechSci Research 根據公司的具體需求提供定制服務。 該報告可以定制為：

公司信息

  • 對其他市場參與者（最多 5 家公司）進行深入分析和概況分析

內容

第 1 章概述

  • 市場定義
  • 市場範圍
    • 目標市場
    • 研究目標年份
    • 主要市場細分

第二章研究方法論

  • 調查目的
  • 基線調查方法
  • 主要行業合作夥伴
  • 主要協會和次要信息
  • 調查方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章執行摘要

  • 市場概覽
  • 主要市場細分概述
  • 主要市場參與者概覽
  • 主要地區/國家概覽
  • 市場驅動因素、挑戰和趨勢概述

第 4 章 VOC（客戶之聲）

第 5 章全球鑑別診斷市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按治療類型（胸痛、頭痛、發燒、肺炎、高血壓、疲勞、睡眠障礙）
    • 按可用性（身體健康障礙、心理健康障礙）
    • 最終用戶（醫院、診斷中心等）
    • 按地區
    • 按公司分類（2022 年）
  • 產品地圖
    • 按治療類型
    • 按可用性
    • 最終用戶
    • 按地區

第六章北美鑑別診斷市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按治療類型（胸痛、頭痛、發燒、肺炎、高血壓、疲勞、睡眠障礙）
    • 按可用性（身體健康障礙、心理健康障礙）
    • 最終用戶（醫院、診斷中心等）
    • 按國家
  • 北美：國家/地區分析
    • 美國
    • 加拿大
    • 墨西哥

第七章歐洲鑑別診斷市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按治療類型（胸痛、頭痛、發燒、肺炎、高血壓、疲勞、睡眠障礙）
    • 按可用性（身體健康障礙、心理健康障礙）
    • 最終用戶（醫院、診斷中心等）
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙

第八章亞太地區鑑別診斷市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按治療類型（胸痛、頭痛、發燒、肺炎、高血壓、疲勞、睡眠障礙）
    • 按可用性（身體健康障礙、心理健康障礙）
    • 最終用戶（醫院、診斷中心等）
    • 按國家
  • 亞太地區：國家/地區分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第9章南美鑑別診斷市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按治療類型（胸痛、頭痛、發燒、肺炎、高血壓、疲勞、睡眠障礙）
    • 按可用性（身體健康障礙、心理健康障礙）
    • 最終用戶（醫院、診斷中心等）
    • 按國家
  • 南美洲：：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章中東和非洲鑑別診斷市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按治療類型（胸痛、頭痛、發燒、肺炎、高血壓、疲勞、睡眠障礙）
    • 按可用性（身體健康障礙、心理健康障礙）
    • 最終用戶（醫院、診斷中心等）
    • 按國家
  • MEA：國家分析
    • 南非鑑別診斷
    • 沙特阿拉伯鑑別診斷
    • 阿聯酋鑑別診斷

第 11 章市場動態

  • 司機
  • 任務

第12章市場趨勢與發展

第 13 章全球鑑別診斷市場：SWOT 分析

第 14 章波特的五力分析

  • 行業競爭
  • 新進入的可能性
  • 供應商的力量
  • 客戶力量
  • 替代品的威脅

第15章競爭格局

  • 業務概覽
  • 提供的產品
  • 最新趨勢
  • 財務信息（公開數據）
  • 管理團隊
  • SWOT 分析
    • Thermo Fisher Scientific Inc.
    • Hologic, Inc.
    • Quidel Corporation.
    • F. Hoffmann-La Roche Ltd.
    • Abbott Laboratories, Inc.
    • Danaher Corporation
    • Meridian Bioscience Inc.
    • GenMark Diagnostics, Inc.
    • Sekisui Diagnostics Co., Ltd.
    • Luminex Corporation.

第16章 戰略建議

簡介目錄
Product Code: 14697

Global Differential Diagnostics Market is anticipated to witness a growth of steady CAGR in the forecast period, 2024-2028. This can be ascribed to the increasing prevalence of various types of diseases such as influenza, COVID diseases, cardiac diseases, and infectious diseases across the globe. Also, the growing accessibility of point-of-care testing products through online platforms will drive the growth of the market in the forecast period. Similarly, growing healthcare decentralization and high investments and funding for project development are expected to enhance the growth of the differential diagnostic market in the coming years. The availability of affordable diagnostic tests for chronic illness in the developing region is anticipated to propel the growth of the market. In January 2022, the Therapeutic Goods Administration (TGA) granted provisional approval for Novavax's COVID-19 vaccine branded as Nuvaxovid for use in Australia.

Rising the Diagnostic Tests

Due to the growing number of diagnostic tests, people are demanding the best diagnostic test which will easily detect diseases and is anticipated to boost the growth of the market during the forecasted period. Diagnostic tests are performed in a private or public laboratory with appropriate equipment and sometimes expensive instrumentation and staffed with trained and qualified personnel. Growing demand for point-of-care testing which occurs at the nearest site of patient care is sought in the field of infectious bacterial diagnostics to allow the care team to receive more results quickly and make immediate and informed management decisions. For molecular diagnosis, different types of diseases can be detected by using challenging differential diagnosis. Governments and different organizations are investing for research and development purposes in the healthcare sector which is a major factor in driving the growth of the differential diagnostics market during the forecasted period. In 2021, according to the National Aids Control Organization (NACO), approximately 2.40 million people in India were infected with HIV. Of the total HIV-infected population 45% were women and 2% were below 12. Also, a growing number of clinics will enhance the demand for differential diagnostic tests market over the years. According to the Non-communicable Diseases Key Facts published by the World Health Organization (WHO) in April 2021, chronic diseases kill around 41 million people each year, which is equivalent to 71% of all deaths worldwide.

Growing Technological Advancements

Growing advancements in diagnostic technology helped physicians to evaluate processes and events in real time. The clinical application of advances in physics and mathematics resulted in the development of diagnostic tools. These developments help physicians to get more accurate, less invasive, and less expensive which will boost the market growth during the forecasted years. Also, the growing demand for diagnostic kits for at-home usage has resulted in technical developments which are expected to create significant growth in the forecast period. Leica Microsystems, a Danaher subsidiary, declared the debut of STELLARIS, the company's flagship platform for its revolutionary confocal microscope, in April 2020. This platform allows the viewing of live tissues and cells in three dimensions.

Market Segmentation

Global Differential Diagnostics Market is segmented into treatment type, usability, end use, and by region. Based on treatment type, the market can be segmented into Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, and Sleep Problems. Based on Usability, the market can be segmented into Systems, Kits, Assays, Reagents, and Consumables. Based on end use, the market can be differentiated into Hospitals, Diagnostic Centers, and Others. Regionally, North America dominates the market among Asia Pacific, Europe, Middle East & Africa, and South America. In terms of country, the United States region is dominating the overall globe in the differential diagnostics market. According to CDC in 2020, 79,611,982 people tested for COVID-19 in the United States. This can be ascribed to the increasingly cost-effective covid-19 testing technology in the healthcare sector.

Recent Development

  • In January 2021, Roche introduced its Cobas Pulse System in a few nations that accepted the CE Mark. The item is a networked point-of-care solution from Roche Diagnostics' most recent generation. The most recent release provides expert blood glucose management.
  • In September 2021, Ortho Clinical Diagnostics announced that Immediate Spin Crossmatch (ISXM), a tool for identifying recipient and donor incompatibility in blood transfusions, will be made available on the company's Ortho Vision and Ortho Vision Max Analyzers.

Market Players

Thermo Fisher Scientific Inc., Hologic, Inc., Quidel Corporation., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Inc, Danaher Corporation, Meridian Bioscience Inc., GenMark Diagnostics, Inc., Sekisui Diagnostics Co., Ltd., Luminex Corporation. are some of the leading players operating in the Global Differential Diagnostics Market.

Report Scope:

In this report, Global Differential Diagnostics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Differential Diagnostics Market, By Treatment Type:

  • Chest Pain
  • Headache
  • Fever
  • Pneumonia
  • Hypertension
  • Fatigue
  • Sleep Problems

Differential Diagnostics Market, By Usability:

  • Physical Health Disorders
  • Mental Health Disorders

Differential Diagnostics Market, By End Use:

  • Hospitals
  • Diagnostic Centers
  • Others

Differential Diagnostics Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Differential Diagnostics Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Differential Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)
    • 5.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)
    • 5.2.3. By End Use (Hospitals, Diagnostic Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Product Map
    • 5.3.1. By Treatment Type
    • 5.3.2. By Usability
    • 5.3.3. By End Use
    • 5.3.4. By Region

6. North America Differential Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)
    • 6.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)
    • 6.2.3. By End Use (Hospitals, Diagnostic Centers, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Differential Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Treatment Type
        • 6.3.1.2.2. By Usability
        • 6.3.1.2.3. By End Use
    • 6.3.2. Canada Differential Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Treatment Type
        • 6.3.2.2.2. By Usability
        • 6.3.2.2.3. By End Use
    • 6.3.3. Mexico Differential Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Treatment Type
        • 6.3.3.2.2. By Usability
        • 6.3.3.2.3. By End Use

7. Europe Differential Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)
    • 7.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)
    • 7.2.3. By End Use (Hospitals, Diagnostic Centers, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Differential Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Treatment Type
        • 7.3.1.2.2. By Usability
        • 7.3.1.2.3. By End Use
    • 7.3.2. Germany Differential Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Treatment Type
        • 7.3.2.2.2. By Usability
        • 7.3.2.2.3. By End Use
    • 7.3.3. United Kingdom Differential Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Treatment Type
        • 7.3.3.2.2. By Usability
        • 7.3.3.2.3. By End Use
    • 7.3.4. Italy Differential Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Treatment Type
        • 7.3.4.2.2. By Usability
        • 7.3.4.2.3. By End Use
    • 7.3.5. Spain Differential Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Treatment Type
        • 7.3.5.2.2. By Usability
        • 7.3.5.2.3. By End Use

8. Asia-Pacific Differential Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)
    • 8.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)
    • 8.2.3. By End Use (Hospitals, Diagnostic Centers, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Differential Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Treatment Type
        • 8.3.1.2.2. By Usability
        • 8.3.1.2.3. By End Use
    • 8.3.2. India Differential Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Treatment Type
        • 8.3.2.2.2. By Usability
        • 8.3.2.2.3. By End Use
    • 8.3.3. Japan Differential Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Treatment Type
        • 8.3.3.2.2. By Usability
        • 8.3.3.2.3. By End Use
    • 8.3.4. South Korea Differential Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Treatment Type
        • 8.3.4.2.2. By Usability
        • 8.3.4.2.3. By End Use
    • 8.3.5. Australia Differential Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Treatment Type
        • 8.3.5.2.2. By Usability
        • 8.3.5.2.3. By End Use

9. South America Differential Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)
    • 9.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)
    • 9.2.3. By End Use (Hospitals, Diagnostic Centers, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Differential Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Treatment Type
        • 9.3.1.2.2. By Usability
        • 9.3.1.2.3. By End Use
    • 9.3.2. Argentina Differential Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Treatment Type
        • 9.3.2.2.2. By Usability
        • 9.3.2.2.3. By End Use
    • 9.3.3. Colombia Differential Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Treatment Type
        • 9.3.3.2.2. By Usability
        • 9.3.3.2.3. By End Use

10. Middle East and Africa Differential Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)
    • 10.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)
    • 10.2.3. By End Use (Hospitals, Diagnostic Centers, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Differential Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Treatment Type
        • 10.3.1.2.2. By Usability
        • 10.3.1.2.3. By End Use
    • 10.3.2. Saudi Arabia Differential Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Treatment Type
        • 10.3.2.2.2. By Usability
        • 10.3.2.2.3. By End Use
    • 10.3.3. UAE Differential Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Treatment Type
        • 10.3.3.2.2. By Usability
        • 10.3.3.2.3. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Global Differential Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1. Thermo Fisher Scientific Inc.
    • 15.6.2. Hologic, Inc.
    • 15.6.3. Quidel Corporation.
    • 15.6.4. F. Hoffmann-La Roche Ltd.
    • 15.6.5. Abbott Laboratories, Inc.
    • 15.6.6. Danaher Corporation
    • 15.6.7. Meridian Bioscience Inc.
    • 15.6.8. GenMark Diagnostics, Inc.
    • 15.6.9. Sekisui Diagnostics Co., Ltd.
    • 15.6.10. Luminex Corporation.

16. Strategic Recommendations